Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal

被引:1
作者
Rezaee, Michael E. [1 ,2 ]
Pallauf, Maximilian [1 ,2 ,3 ]
Fletcher, Sean A. [1 ,2 ]
Pavlovich, Christian P. [1 ,2 ]
Baraban, Ezra [4 ]
Ged, Yasser [2 ]
Singla, Nirmish [1 ,2 ,5 ]
机构
[1] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21218 USA
[3] Paracelsus Med Univ, Univ Salzburg, Dept Urol, Salzburg, Austria
[4] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA
关键词
Kidney cancer; Non-clear cell; Staging; Prognosis; Renal vein; NEPHRECTOMY; SURVIVAL; RISK;
D O I
10.1016/j.urolonc.2024.01.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To examine the prognostic significance of perinephric fat, renal sinus fat, and renal vein invasion in patients with pT3a renal Methods: A population-based retrospective cohort study of patients with pT3aN0M0 RCC was performed using Surveillance, Epidemiology, and End Results (SEER) data for the years 2010 through 2019. Cox proportional hazards models were used to examine the relationship between pT3a subclassification groups and cancer-specific survival (CSS) by histological subtype (clear cell, papillary, chromophobe, Results: The cohort consisted of 10,170 patients with pT3a RCC, including 8,446 (83.0%) with clear cell RCC and 1,724 (17.0%) with nonclear cell RCC (nccRCC). Median follow up was 36 months. Differences in CSS by pT3a subclassification groups were observed in all histological subtypes but were most pronounced in nccRCC, specifically papillary RCC. Compared to perinephric fat (PF) invasion only, renal vein (RV) invasion (HR = 4.9, 95%CI: 2.5-9.3, P < 0.01), renal sinus fat invasion (HR = 3.0, 95%CI: 1.4-6.2), RV and PF invasion (HR = 7.5, 95%CI: 3.5-16.0), and combination of all three characteristics (HR = 4.4, 95%CI: 1.2-15.5) were associated with worse CSS in patients with papillary RCC. Conclusion: We examined the prognostic role of pT3a staging subclassifications in RCC by histologic subtype and observed survival differences, particularly in papillary RCC. Our findings highlight the need to refine pT3a staging criteria to help guide individualized, multimodal treatment strategies for locally advanced RCC. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页码:119e23 / 119e29
页数:7
相关论文
共 29 条
[1]  
American Cancer Society, 2022, Key statistics about kidney cancer
[2]  
American Cancer Society, Survival rates for kidney cancer
[3]   Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma [J].
Choueiri, T. K. ;
Tomczak, P. ;
Park, S. H. ;
Venugopal, B. ;
Ferguson, T. ;
Chang, Y. -H. ;
Hajek, J. ;
Symeonides, S. N. ;
Lee, J. L. ;
Sarwar, N. ;
Thiery-Vuillemin, A. ;
Gross-Goupil, M. ;
Mahave, M. ;
Haas, N. B. ;
Sawrycki, P. ;
Gurney, H. ;
Chevreau, C. ;
Melichar, B. ;
Kopyltsov, E. ;
Alva, A. ;
Burke, J. M. ;
Doshi, G. ;
Topart, D. ;
Oudard, S. ;
Hammers, H. ;
Kitamura, H. ;
Bedke, J. ;
Perini, R. F. ;
Zhang, P. ;
Imai, K. ;
Willemann-Rogerio, J. ;
Quinn, D. I. ;
Powles, T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08) :683-694
[4]   Comprehensivemolecular characterization of clear cell renal cell carcinoma [J].
Creighton, Chad J. ;
Morgan, Margaret ;
Gunaratne, Preethi H. ;
Wheeler, David A. ;
Gibbs, Richard A. ;
Robertson, A. Gordon ;
Chu, Andy ;
Beroukhim, Rameen ;
Cibulskis, Kristian ;
Signoretti, Sabina ;
Vandin, Fabio ;
Wu, Hsin-Ta ;
Raphael, Benjamin J. ;
Verhaak, Roel G. W. ;
Tamboli, Pheroze ;
Torres-Garcia, Wandaliz ;
Akbani, Rehan ;
Weinstein, John N. ;
Reuter, Victor ;
Hsieh, James J. ;
Brannon, A. Rose ;
Hakimi, A. Ari ;
Jacobsen, Anders ;
Ciriello, Giovanni ;
Reva, Boris ;
Ricketts, Christopher J. ;
Linehan, W. Marston ;
Stuart, Joshua M. ;
Rathmell, W. Kimryn ;
Shen, Hui ;
Laird, Peter W. ;
Muzny, Donna ;
Davis, Caleb ;
Morgan, Margaret ;
Xi, Liu ;
Chang, Kyle ;
Kakkar, Nipun ;
Trevino, Lisa R. ;
Benton, Susan ;
Reid, Jeffrey G. ;
Morton, Donna ;
Doddapaneni, Harsha ;
Han, Yi ;
Lewis, Lora ;
Dinh, Huyen ;
Kovar, Christie ;
Zhu, Yiming ;
Santibanez, Jireh ;
Wang, Min ;
Hale, Walker .
NATURE, 2013, 499 (7456) :43-+
[5]   The Association Between Socioeconomic Status, Renal Cancer Presentation, and Survival in the United States: A Survival, Epidemiology, and End Results Analysis [J].
Danzig, Matthew R. ;
Weinberg, Aaron C. ;
Ghandour, Rashed A. ;
Kotamarti, Srinath ;
McKiernan, James M. ;
Badani, Ketan K. .
UROLOGY, 2014, 84 (03) :583-589
[6]   Pathologic T3a renal cell carcinoma: a classification in need of further refinement [J].
DiBianco, John M. ;
Gomella, Patrick ;
Ball, Mark W. .
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
[7]   Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) Database [J].
Doll, Kern' M. ;
Rademaker, Alfred ;
Sosa, Julie A. .
JAMA SURGERY, 2018, 153 (06) :588-589
[8]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[9]   TNM Staging for Renal Cell Carcinoma: Time for a New Method [J].
Eggener, Scott .
EUROPEAN UROLOGY, 2010, 58 (04) :517-519
[10]   Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis [J].
Guo, Pengju ;
Wang, Yongxing ;
Han, Yili ;
Wei, Dechao ;
Zhao, Jiahui ;
Li, Mingchuan ;
Jiang, Yongguang ;
Luo, Yong .
FRONTIERS IN ONCOLOGY, 2021, 11